Cargando…

Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia

AIMS: While COVID-19 affects the cardiovascular system, the potential clinical impact of cardiovascular biomarkers on predicting outcomes in COVID-19 patients is still unknown. Therefore, to investigate this issue we analyzed the prognostic potential of cardiac biomarkers on in-hospital and long-ter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motloch, Lukas J., Jirak, Peter, Gareeva, Diana, Davtyan, Paruir, Gumerov, Ruslan, Lakman, Irina, Tataurov, Aleksandr, Zulkarneev, Rustem, Kabirov, Ildar, Cai, Benzhi, Valeev, Bairas, Pavlov, Valentin, Kopp, Kristen, Hoppe, Uta C., Lichtenauer, Michael, Fiedler, Lukas, Pistulli, Rudin, Zagidullin, Naufal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273888/ https://www.ncbi.nlm.nih.gov/pubmed/35836945 http://dx.doi.org/10.3389/fmed.2022.906665

Ejemplares similares

Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia
por: Fiedler, Lukas, et al.
Publicado: (2022)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors
por: Motloch, Lukas J., et al.
Publicado: (2022)

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
por: Fiedler, Lukas, et al.
Publicado: (2023)

J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
por: Zagidullin, Naufal Shamilevich, et al.
Publicado: (2021)

Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction
por: Zagidullin, Naufal, et al.
Publicado: (2020)

SERUM BIOMARKERS IN MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA IN EARLY AND REMOTE PERIOD
por: Zagidullin, Naufal, et al.
Publicado: (2022)

OSBORNE WAVE IN ECG AS A PREDICTOR OF HOSPITAL MORTALITY IN COVID-19 ASSOCIATED PNEUMONIA
por: Zagidullin, Naufal, et al.
Publicado: (2021)

Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy
por: Paar, Vera, et al.
Publicado: (2019)

Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation
por: Zulkarneev, Rustem, et al.
Publicado: (2012)

Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine
por: Ohnewein, Bernhard, et al.
Publicado: (2023)

The Impact of Remote Ischemic Preconditioning on Arterial Stiffness and Heart Rate Variability in Patients with Angina Pectoris
por: Zagidullin, Naufal, et al.
Publicado: (2016)

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
por: Jirak, Peter, et al.
Publicado: (2020)

Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
por: Jirak, Peter, et al.
Publicado: (2022)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis
por: Jirak, Peter, et al.
Publicado: (2022)

Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe Pneumonia
por: Jirak, Peter, et al.
Publicado: (2021)

Editorial: Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches
por: Zagidullin, Naufal, et al.
Publicado: (2021)

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020)

Myocardial injury in severe COVID‐19 is similar to pneumonias of other origin: results from a multicentre study
por: Jirak, Peter, et al.
Publicado: (2020)

Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study
por: Boxhammer, Elke, et al.
Publicado: (2023)

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome
por: Topf, Albert, et al.
Publicado: (2022)

Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure
por: Jirak, Peter, et al.
Publicado: (2017)

Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration
por: Gong, Rui, et al.
Publicado: (2021)

Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: comparison to other types of severe pneumonia
por: Jirak, P, et al.
Publicado: (2021)

Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction
por: Kopp, Kristen, et al.
Publicado: (2023)

Subcutaneous administration of levothyroxine: a novel approach to refractory hypothyroidism – A review and a case report
por: Topf, Albert, et al.
Publicado: (2021)

Autoimmune myocarditis is not associated with left ventricular systolic dysfunction
por: Mirna, Moritz, et al.
Publicado: (2019)

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
por: Paar, Vera, et al.
Publicado: (2020)

Management of Implantable Cardioverter-Defibrillators during Pregnancy—A Systematic Review
por: Topf, Albert, et al.
Publicado: (2021)

Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome, Acute Coronary Syndrome and Healthy Individuals
por: Topf, Albert, et al.
Publicado: (2022)

Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications
por: Guo, Xiaofei, et al.
Publicado: (2018)

Interdisciplinary Model for Scheduling Post-discharge Cardiopulmonary Care of Patients Following Severe and Critical SARS-CoV-2 (Coronavirus) Infection
por: Kopp, Kristen, et al.
Publicado: (2020)

Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death
por: Shomanova, Zornitsa, et al.
Publicado: (2020)

Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study
por: Rezar, Richard, et al.
Publicado: (2021)

Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome—A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage
por: Topf, Albert, et al.
Publicado: (2022)

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
por: Topf, Albert, et al.
Publicado: (2021)

Cyclin L1 controls cardiomyocyte proliferation and heart repair after injury
por: Gong, Rui, et al.
Publicado: (2023)

Assessment of Cardiac Remodeling—A Chance for Novel Cardiac Biomarkers?
por: Jirak, Peter, et al.
Publicado: (2020)

UCP2 Modulates Cardioprotective Effects of Ru360 in Isolated Cardiomyocytes during Ischemia
por: Motloch, Lukas J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hna4ft64ms6fmlk85pu8noup0q